Latest Stock Market News

Red Mountain Mining has bolstered its critical minerals portfolio with key acquisitions in the US and promising exploration outcomes across its global projects, supported by a recent $1.5 million capital raise.

Trigg Minerals has initiated the process for a Nasdaq dual listing via an American Depositary Receipt program, aiming to tap into the world’s largest capital market. The company also raised A$2.5 million from Tribeca Investment Partners, reinforcing its growth strategy.

Eclipse Metals has advanced its Greenland rare earths project with expanded drilling and a key licence renewal, while preparing for a NASDAQ dual listing to tap North American investors.

Eclipse Metals announces plans for a NASDAQ dual listing to boost its rare earth elements strategy and tap into North American capital markets, while maintaining its ASX presence.

Red Mountain Mining reports impressive rock chip assay results from its Armidale Antimony-Gold Project in NSW, revealing strong antimony grades up to 36.3% and gold presence, while advancing exploration efforts in both Australia and the US.

Red Mountain Mining has secured the Yellow Pine Antimony Project in Idaho’s historic Stibnite Mining District, positioning itself near Perpetua Resources’ major gold-antimony reserve. The company’s recent $1.5 million capital raise will fund exploration efforts across this and its Utah project.

Brickworks Limited will be removed from the S&P/ASX 200 index on 16 September 2025 following its acquisition of Washington H. Soul Pattinson. Catalyst Metals Limited will replace it, marking a notable shift in the index composition.

S&P Dow Jones Indices has announced its September 2025 quarterly rebalance, with significant additions and removals across multiple ASX indices set to take effect before market open on September 22.

CLINUVEL Pharmaceuticals is preparing to elevate its American Depository Receipt program to a Nasdaq Level II listing by the end of 2025, aiming to enhance visibility and trading access in the U.S. without altering its primary ASX listing.

London City Equities reported a $11.3 million capital gain primarily from trimming its Fiducian Group stake, reversing prior losses to post a $500,000 profit and declaring a 2.5 cent fully franked dividend including a special payout.

Advanced Health Intelligence has been formally delisted from NASDAQ due to shareholder equity deficiencies but is actively pursuing ASX reinstatement as a critical step toward regaining its dual-listing status.

Micro-X Limited's trading suspension has been lifted following its announcement of an equity raising, signaling renewed market activity for the medical technology firm.